Table 2 Outcomes
From: T.E.A. Study: three-day ertapenem versus three-day Ampicillin-Sulbactam
Diagnosis | Ertapenem group | Ampicillin- Sulbactam group | p |
|---|---|---|---|
Superficial/Deep Infections | 2/0 | 8/2 | 0.03 |
Mortality | 1 (AMI) | 1 (PE) | n.s. |
Morbidity | 21 | 19 | n.s. |
PE | 1 | 1 | n.s. |
DVT | 3 | 4 | n.s. |
AMI | 1 | 1 | n.s. |
Pneumoniae | 6 | 5 | n.s. |
Prolonged ileus | 4 | 4 | n.s. |
UTI | 3 | 3 | n.s. |
TIA | 1 | 0 | n.s. |
Biliary leaks | 2 | 1 | n.s. |
Cure/Failure | 69/2 | 51/10 | 0.03 |